Tg Therapeutics Stock Market Value
| TGTX Stock | USD 34.61 0.46 1.31% |
| Symbol | TGTX |
TG Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TG Therapeutics. If investors know TGTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TG Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.10) | Revenue Per Share 1.829 | Quarterly Revenue Growth (0.49) | Return On Assets (0.0007) |
The market value of TG Therapeutics is measured differently than its book value, which is the value of TGTX that is recorded on the company's balance sheet. Investors also form their own opinion of TG Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is TG Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TG Therapeutics' market value can be influenced by many factors that don't directly affect TG Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TG Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TG Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TG Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TG Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TG Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TG Therapeutics.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in TG Therapeutics on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding TG Therapeutics or generate 0.0% return on investment in TG Therapeutics over 30 days. TG Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commer... More
TG Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TG Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TG Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.92 | |||
| Information Ratio | 0.1221 | |||
| Maximum Drawdown | 24.51 | |||
| Value At Risk | (4.62) | |||
| Potential Upside | 7.62 |
TG Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TG Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TG Therapeutics' standard deviation. In reality, there are many statistical measures that can use TG Therapeutics historical prices to predict the future TG Therapeutics' volatility.| Risk Adjusted Performance | 0.1261 | |||
| Jensen Alpha | 0.3715 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.1285 | |||
| Treynor Ratio | 0.2983 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TG Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TG Therapeutics Backtested Returns
TG Therapeutics appears to be not too volatile, given 3 months investment horizon. TG Therapeutics retains Efficiency (Sharpe Ratio) of 0.17, which indicates the firm had a 0.17% return per unit of price deviation over the last 3 months. By examining TG Therapeutics' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please review TG Therapeutics' Risk Adjusted Performance of 0.1261, mean deviation of 2.93, and Downside Deviation of 3.92 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, TG Therapeutics holds a performance score of 13. The entity owns a Beta (Systematic Risk) of 2.09, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TG Therapeutics will likely underperform. Please check TG Therapeutics' value at risk, and the relationship between the standard deviation and kurtosis , to make a quick decision on whether TG Therapeutics' current price history will revert.
Auto-correlation | 0.61 |
Good predictability
TG Therapeutics has good predictability. Overlapping area represents the amount of predictability between TG Therapeutics time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TG Therapeutics price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current TG Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 4.6 |
TG Therapeutics lagged returns against current returns
Autocorrelation, which is TG Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TG Therapeutics' stock expected returns. We can calculate the autocorrelation of TG Therapeutics returns to help us make a trade decision. For example, suppose you find that TG Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
TG Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TG Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TG Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TG Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
TG Therapeutics Lagged Returns
When evaluating TG Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TG Therapeutics stock have on its future price. TG Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TG Therapeutics autocorrelation shows the relationship between TG Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in TG Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.